Herb-drug interactions with Danshen (Salvia miltiorrhiza): A review on the role of cytochrome P450 enzymes

Drug Metabolism and Drug Interactions

Volumn 27, Issue 1, 2012, Pages 9-18

  Zhou, Xuelin ^a   Chan, Kelvin ^b,c   Yeung, John H K ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

cytochrome P450; herb drug interaction; probe substrate; Salvia miltiorrhiza; warfarin

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; BORNEOL; CARDIOVASCULAR AGENT; CRYPTOTANSHINONE; CYTOCHROME P450; CYTOCHROME P450 2C; CYTOCHROME P450 2D; CYTOCHROME P450 3A; DIGOXIN; ERYTHROMYCIN; HERBACEOUS AGENT; ISOENZYME; LITHOSPERMIC ACID; METOPROLOL; PROTOCATECHUALDEHYDE; SALVIANOLIC ACID B; TANSHINONE I; TANSHINONE IIA; VERAPAMIL; WARFARIN;

CLINICAL TRIAL (TOPIC); DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG METABOLISM; ENZYME INDUCTION; HEPATITIS B; HERB DRUG INTERACTION; HUMAN; HYPERCHOLESTEROLEMIA; LIVER CIRRHOSIS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SALVIA MILTIORRHIZA; SINGLE DRUG DOSE;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CYTOCHROME P-450 ENZYME SYSTEM; HERB-DRUG INTERACTIONS; HUMANS; SALVIA MILTIORRHIZA;

EID: 84860516394     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/dmdi-2011-0038     Document Type: Review

References (149)

1. Zhou L, Zuo Z, Chow MS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005;45:1345-59. (Pubitemid 41643896)
2. Comission CP, editor. Chinese Pharmacopoeia 2010. Beijing: China Medical Science Press, 2010.
3. Cheng TO. Cardiovascular effects of Danshen. Int J Cardiol 2007;121:9-22. (Pubitemid 47287779)
4. Lin TH, Hsieh CL. Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction. Chin Med 2010;5:22.
5. Ling S, Nheu L, Dai A, Guo Z, Komesaroff P. Effects of four medicinal herbs on human vascular endothelial cells in culture. Int J Cardiol 2008;128:350-8.
6. Lam FF, Deng SY, Ng ES, Yeung JH, Kwan YW, Lau CB, et al. Mechanisms of the relaxant effect of a Danshen and Gegen formulation on rat isolated cerebral basilar artery. J Ethnopharmacol 2010;132:186-92.
7. Lam FF, Yeung JH, Chan KM, Or PM. Relaxant effects of Danshen aqueous extract and its constituent danshensu on rat coronary artery are mediated by inhibition of calcium channels. Vascul Pharmacol 2007;46:271-7. (Pubitemid 46124091)
8. Lam FF, Yeung JH, Cheung JH, Or PM. Pharmacological evidence for calcium channel inhibition by Danshen (Salvia milti-orrhiza) on rat isolated femoral artery. J Cardiovasc Pharmacol 2006;47:139-45. (Pubitemid 44378237)
9. Lam FF, Yeung JH, Kwan YW, Chan KM, Or PM. Salvianolic acid B, an aqueous component of Danshen (Salvia miltiorrhiza), relaxes rat coronary artery by inhibition of calcium channels. Eur J Pharmacol 2006;553:240-5. (Pubitemid 44779601)
10. Lam FF, Seto SW, Kwan YW, Yeung JH, Chan P. Activation of the iberiotoxin-sensitive BKCa channels by salvianolic acid B of the porcine coronary artery smooth muscle cells. Eur J Pharmacol 2006;546:28-35. (Pubitemid 44331850)
11. Lam FF, Yeung JH, Cheung JH. Mechanisms of the dilator action of Danshen (Salvia miltiorrhiza) on rat isolated femoral artery. J Cardiovasc Pharmacol 2005;46:361-8. (Pubitemid 41262840)
12. Lam FF, Yeung JH, Chan KM, Or PM. Mechanisms of the dilator action of cryptotanshinone on rat coronary artery. Eur J Pharmacol 2008;578:253-60. (Pubitemid 350309589)
13. Lam FF, Yeung JH, Chan KM, Or PM. Dihydrotanshinone, a lipophilic component of Salvia miltiorrhiza (Danshen), relaxes rat coronary artery by inhibition of calcium channels. J Ethnopharmacol 2008;119:318-21.
14. Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, et al. Ameliorating effects of compounds derived from Salvia mil-tiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther 2008;117:280-95.
15. Park JW, Lee SH, Yang MK, Lee JJ, Song MJ, Ryu SY, et al. 15, 16-dihydrotanshinone I, a major component from Salvia mil-tiorrhiza Bunge (Dansham), inhibits rabbit platelet aggregation by suppressing intracellular calcium mobilization. Arch Pharm Res 2008;31:47-53.
16. Zhao L, Gaudry L, Dunkley S, Brighton T, Guo ZX, Ye ZL, et al. Modulation of platelet and leucocyte function by a Chinese herbal formulation as compared with conventional antiplatelet agents. Platelets 2008;19:24-31. (Pubitemid 351171557)
17. Fan HY, Fu FH, Yang MY, Xu H, Zhang AH, Liu K. Antiplatelet and antithrombotic activities of salvianolic acid A. Thromb Res 2010;126:e17-22.
18. Huang ZS, Zeng CL, Zhu LJ, Jiang L, Li N, Hu H. Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase. J Thromb Haemost 2010;8:1383-93.
19. Zou ZW, Xu LN, Tian JY. Antithrombotic and antiplatelet effects of rosmarinic acid, a water-soluble component isolated from radix Salviae miltiorrhizae (Danshen). [in Chinese]. Yao Xue Xue Bao/Acta Pharma Sinica 1993;28:241-5.
20. Lo AC, Chan K, Yeung JH, Woo KS. The effects of Danshen (Salvia miltiorrhiza) on pharmacokinetics and pharmacody-namics of warfarin in rats. Eur J Drug Metab Pharmacokinet 1992;17:257-62. (Pubitemid 23107958)
21. Chan T Y. Interaction between warfarin and Danshen (Salvia mil-tiorrhiza). Ann Pharmacother 2001;35:501-4. (Pubitemid 32260218)
22. Yu CM, Chan JC, Sanderson JE. Chinese herbs and warfarin po-tentiation by 'Danshen'. J Intern Med 1997;241:337-9. (Pubitemid 27224000)
23. Izzo AA, Di Carlo G, Borrelli F, Ernst E. Cardiovascular pharma-cotherapy and herbal medicines: the risk of drug interaction. Int J Cardiol 2005;98:1-14. (Pubitemid 40169845)
24. Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005;165:1095-106. (Pubitemid 40720733)
25. Li H, Wang S, Zhang B, Xie Y, Wang J, Yang Q, et al. Influence of co-administered danshensu on pharmacokinetic fate and tissue distribution of paeonol in rats. Planta Med 2012;78:135-40.
26. Chu Y, Zhang L, Wang XY, Guo JH, Guo ZX, Ma XH. The effect of compound Danshen dripping pills, a Chinese herb medicine, on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Ethnopharmacol 2011;137:1457-61.
27. Chan HT, So LT, Li SW, Siu CW, Lau CP, Tse HF. Effect of herbal consumption on time in therapeutic range of warfarin therapy in patients with atrial fibrillation. J Cardiovasc Pharmacol 2011;58:87-90.
28. Chan K, Lo AC, Yeung JH, Woo KS. The effects of Danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and phar-macokinetics of warfarin enantiomers in rats. J Pharm Pharmacol 1995;47:402-6.
29. Wu WW, Yeung JH. Inhibition of warfarin hydroxylation by major tanshinones of Danshen (Salvia miltiorrhiza) in the rat in vitro and in vivo. Phytomedicine 2010;17:219-26.
30. Liu J, Wang X, Cai Z, Lee FS. Effect of tanshinone IIA on the non-covalent interaction between warfarin and human serum albumin studied by electrospray ionization mass spectrometry. J Am Soc Mass Spectrom 2008;19:1568-75.
31. Li YG, Song L, Liu M, Hu ZB, Wang ZT. Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen). J Chromatogr A 2009;1216:1941-53.
32. Ong ES, Len SM. Evaluation of pressurized liquid extraction and pressurized hot water extraction for tanshinone I and IIA in Salvia miltior-rhiza using LC and LC-ESI-MS. J Chromatogr Sci 2004;42:211-6.
33. Li X, Yu C, Cai Y, Liu G, Jia J, Wang Y. Simultaneous determination of six phenolic constituents of Danshen in human serum using liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2005;820:41-7. (Pubitemid 40615436)
34. Li P, Li SP, Yang FQ, Wang YT. Simultaneous determination of four tanshinones in Salvia miltiorrhiza by pressurized liquid extraction and capillary electrochromatography. J Sep Sci 2007;30:900-5. (Pubitemid 46736412)
35. Yuan D, Pan YN, Fu WW, Makino T, Kano Y. Quantitative analysis of the marker compounds in Salvia miltiorrihiza root and its phytomedicinal preparations. Chem Pharm Bull (Tokyo) 2005;53:508-14. (Pubitemid 40740618)
36. Zhang JL, Cui M, He Y, Yu HL, Guo DA. Chemical finger-print and metabolic fingerprint analysis of Danshen injection by HPLC-UV and HPLC-MS methods. J Pharm Biomed Anal 2005;36:1029-35. (Pubitemid 40037823)
37. Liu AH, Li L, Xu M, Lin YH, Guo HZ, Guo DA. Simultaneous quantification of six major phenolic acids in the roots of Salvia miltiorrhiza and four related traditional Chinese medicinal preparations by HPLC-DAD method. J Pharm Biomed Anal 2006;41:48-56.
38. Liu AH, Lin YH, Yang M, Sun JH, Guo H, Guo DA. High-performance liquid chromatographic determination of tanshi-nones in the roots of Salvia miltiorrhiza and related traditional Chinese medicinal preparations. J Pharm Pharm Sci 2006;9:1-9. (Pubitemid 43078830)
39. Zhi W, Deng Q. Purification of salvianolic acid B from the crude extract of Salvia miltiorrhiza with hydrophilic organic/salt-containing aqueous two-phase system by counter-current chroma-tography. J Chromatogr A 2006;1116:149-52.
40. Ma HL, Qin MJ, Qi LW, Wu G, Shu P. Improved quality evaluation of Radix Salvia miltiorrhiza through simultaneous quanti-fication of seven major active components by high-performance liquid chromatography and principal component analysis. Biomed Chromatogr 2007;21:931-9. (Pubitemid 47272329)
41. Gu M, Wang X, Su Z, Ouyang F. One-step separation and pu-rification of 3, 4-dihydroxyphenyllactic acid, salvianolic acid B and protocatechualdehyde from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography. J Chromatogr A 2007;1140:107-11. (Pubitemid 46026779)
42. Yang Q, Zhang XL, Li XY, Tang WK, Zhang JX, Fang CX, et al. Coupling continuous ultrasound-assisted extraction with ultrasonic probe, solid-phase extraction and high-performance liquid chromatography for the determination of sodium Danshensu and four tanshinones in Salvia miltiorrhiza bunge. Anal Chim Acta 2007;589:231-8. (Pubitemid 46517489)
43. Cao J, Wei YJ, Qi LW, Li P, Qian ZM, Luo HW, et al. Determination of fifteen bioactive components in Radix et Rhizoma Salviae Miltiorrhizae by high-performance liquid chro-matography with ultraviolet and mass spectrometric detection. Biomed Chromatogr 2008;22:164-72. (Pubitemid 351260194)
44. Liu Y, Li X, Li Y, Wang L, Xue M. Simultaneous determination of danshensu, rosmarinic acid, cryptotanshinone, tanshinone IIA, tanshinone I and dihydrotanshinone I by liquid chromatograph-ic-mass spectrometry and the application to pharmacokinetics in rats. J Pharm Biomed Anal 2010;53:698-704.
45. Yang H, Han L, Sheng T, He Q, Liang J. Effects of replenishing qi, promoting blood circulation and resolving phlegm on vascular endothelial function and blood coagulation system in senile patients with hyperlipidemia. J Tradit Chin Med 2006;26:120-4. (Pubitemid 46138208)
46. Zhou L, Chow M, Zuo Z. Improved quality control method for Danshen products-consideration of both hydrophilic and lipophilic active components. J Pharm Biomed Anal 2006;41:744-50.
47. Wu BW, Pan TL, Leu YL, Chang YK, Tai PJ, Lin KH, et al. Antiviral effects of Salvia miltiorrhiza (Danshen) against entero-virus 71. Am J Chin Med 2007;35:153-68.
48. Li P, Xu G, Li SP, Wang YT, Fan TP, Zhao QS, et al. Optimizing ultraperformance liquid chromatographic analysis of 10 diterpe-noid compounds in Salvia miltiorrhiza using central composite design. J Agric Food Chem 2008;56:1164-71. (Pubitemid 351364043)
49. Liu JR, Chen GF, Shih HN, Kuo PC. Enhanced antioxidant bio-activity of Salvia miltiorrhiza (Danshen) products prepared using nanotechnology. Phytomedicine 2008;15:23-30.
50. Wang L, Song Y, Cheng Y, Liu X. Orthogonal array design for the optimization of supercritical fluid extraction of tanshinones from Danshen. J Sep Sci 2008;31:321-8. (Pubitemid 351279408)
51. Kan S, Li J, Huang W, Shao L, Chen D. Microsphere resin chroma-tography combined with microbial biotransformation for the separation and purification of salvianolic acid B in aqueous extract of roots of Salvia multiorrihza Bunge. J Chromatogr A 2009;1216:3881-6.
52. Wu K, Zhang Q, Liu Q, Tang F, Long Y, Yao S. Ionic liquid surfactant-mediated ultrasonic-assisted extraction coupled to HPLC: application to analysis of tanshinones in Salvia miltior-rhiza bunge. J Sep Sci 2009;32:4220-6.
53. Wu D, Jiang X, Wu S. Direct purification of tanshinones from Salvia miltiorrhiza Bunge by high-speed counter-current chro-matography without presaturation of the two-phase solvent mixture. J Sep Sci 2010;33:67-73.
54. Sun A, Zhang Y, Li A, Meng Z, Liu R. Extraction and preparative purification of tanshinones from Salvia miltiorrhiza Bunge by high-speed counter-current chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2011;879:1899-904.
55. Feng J, Jin Y, Wang J, Xiao Y, Liang X. Development of full-quantified fingerprint for quality control of traditional Chinese medicines [in Chinese]. Chin J Chromatog 2008;26:180-5.
56. Liu M, Li YG, Zhang F, Yang L, Chou GX, Wang ZT, et al. Chromatographic fingerprinting analysis of Danshen root (Salvia miltiorrhiza Radix et Rhizoma) and its preparations using high performance liquid chromatography with diode array detection and electrospray mass spectrometry (HPLC-DAD-ESI/MS). J Sep Sci 2007;30:2256-67. (Pubitemid 47497027)
57. Wang L, Bao Y, Yang Y, Wu Y, Chen X, Si S, et al. Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay. J Biomol Screen 2010;15:239-50.
58. Liu AH, Guo H, Ye M, Lin YH, Sun JH, Xu M, et al. Detection, characterization and identification of phenolic acids in Danshen using high-performance liquid chromatography with diode array detection and electrospray ionization mass spectrometry. J Chromatogr A 2007;1161:170-82. (Pubitemid 47088514)
59. Zhou R, editor. Resource Science of Chinese Medicinal Materials. Beijing: Medical and Pharmaceutical Science Press, 1993.
60. Zhao LL, Xie K, Zhu SS, Jiang HY, Huo WZ. Quality analysis of Radix Salviae Miltiorrhizae from different habitats by HPLC and TLC. [in Chinese]. Zhong Yao Cai 2007;30:646-8.
61. Li JT, Dong JE, Liang ZS, Shu ZM, Wan GW. Distributional difference of fat-soluble compounds in the roots, stems and leaves of four Salvia plants. [in Chinese]. Fen Zi Xi Bao Sheng Wu Xue Bao/J Mol Cell Biol 2008;41:44-52.
62. Lee CY, Agrawal DC, Wang CS, Yu SM, Chen JJ, Tsay HS. T-DNA activation tagging as a tool to isolate Salvia miltiorrhiza transgenic lines for higher yields of tanshinones. Planta Med 2008;74:780-6. (Pubitemid 351881004)
63. Li CG, Sheng SJ, Pang EC, Marriott P, May B, Zhou S, et al. Cultivar variations of Australian-grown Danshen (Salvia mil-tiorrhiza): bioactive markers and root yields. Chem Biodivers 2009;6:170-81.
64. Qin HY, Suo ZR, Liu WZ. Dynamic changes of content of sal-vianolic acid in vegetative organs of Salvia miltiorrhiza. [in Chinese]. Zhong Yao Cai 2009;32:1199-201.
65. Sheng SJ, Pang EC, Xue CC, Li CG. Seasonal variations in bio-active marker contents in Australian-grown Salvia miltiorrhiza roots. Chem Biodivers 2009;6:551-60.
66. Yuan Y, Liu Y, Lu D, Huang L, Liang R, Yang Z, et al. Genetic stability, active constituent, and pharmacoactivity of Salvia miltiorrhiza hairy roots and wild plant. Z Naturforsch C 2009;64:557-63.
67. Zhong GX, Li P, Zeng LJ, Guan J, Li DQ, Li SP. Chemical characteristics of Salvia miltiorrhiza (Danshen) collected from different locations in China. J Agric Food Chem 2009;57:6879-87.
68. Fu G, Feng X, Ge X, He X, Wu Z, Yang J, et al. Differences in shapes and properties and microscopic frameworks of wild and cultivated Radix Salviae Miltiorrhizae from different regions. Zhongguo Zhong Yao Za Zhi/China J Chin Materia Medica 2010;35:1235-8.
69. Song Z, Li X, Wang H, Wang J. Genetic diversity and population structure of Salvia miltiorrhiza Bge in China revealed by ISSR and SRAP. Genetica 2010;138:241-9.
70. He W, Li Y, Shen XM, Sun LM. Optimization of preparative separation and purification of water-soluble substance from Salvia miltiorrhiza by macroporous resins. [in Chinese]. Zhong Yao Cai 2007;30:1308-10.
71. Sun Y, Zhu H, Wang J, Liu Z, Bi J. Isolation and purification of salvianolic acid A and salvianolic acid B from Salvia miltiorrhiza by high-speed counter-current chromatography and comparison of their antioxidant activity. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:733-7.
72. Tian M, Yan H, Row KH. Solid-phase extraction of tanshino-nes from Salvia Miltiorrhiza Bunge using ionic liquid-modified silica sorbents. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:738-42.
73. Hu P, Luo GA, Zhao ZZ, Jiang ZH. Quantitative determination of four diterpenoids in Radix Salviae Miltiorrhizae using LC-MS-MS. Chem Pharm Bull (Tokyo) 2005;53:705-9. (Pubitemid 40880269)
74. Hu P, Luo GA, Zhao Z, Jiang ZH. Quality assessment of radix sal-viae miltiorrhizae. Chem Pharm Bull (Tokyo) 2005;53:481-6. (Pubitemid 40740613)
75. Cao J, Qi LW, Chen J, Yi L, Li P, Ren MT, et al. Application of liquid chromatography-electrospray ionization time-of-flight mass spectrometry for analysis and quality control of compound Danshen preparations. Biomed Chromatogr 2009;23:397-405.
76. Zhang HS, Wang SQ. Salvianolic acid B from Salvia miltior-rhiza inhibits tumor necrosis factor-alpha (TNF-alpha)-induced MMP-2 upregulation in human aortic smooth muscle cells via suppression of NAD(P)H oxidase-derived reactive oxygen species. J Mol Cell Cardiol 2006;41:138-48.
77. Xu G, Zhao W, Zhou Z, Zhang R, Zhu W, Liu X. Danshen extracts decrease blood C reactive protein and prevent isch-emic stroke recurrence: a controlled pilot study. Phytother Res 2009;23:1721-5.
78. Zhang M, Li X, Qin G, Liu Y, Zhao X. Effects of Danshen injection on the reserve of tissue plasminogen activator and nitric oxide in endothelium and vasodilatation in diabetic patients. [in Chinese]. Zhong Yao Cai 2005;28:529-32.
79. Jin CX, Yang J, Sun HF. Comparative study of the clinical effects of salvia miltiorrhiza injection and shengmai injection on chronic hepatitis B. [in Chinese]. Zhongguo Zhong Xi Yi Jie He Za Zhi/Chin J Integ Trad West Med 2006;26:936-8.
80. Ye F, Liu Y, Qiu G, Zhao Y, Liu M. Clinical study on treatment of cirrhosis by different dosages of salvia injection. [in Chinese]. Zhong Yao Cai 2005;28:850-4.
81. Ji KT, Chai JD, Xing C, Nan JL, Yang PL, Tang JF. Danshen protects endothelial progenitor cells from oxidized low-density lipoprotein induced impairment. J Zhejiang Univ Sci B 2010;11:618-26.
82. Li W, Li ZW, Han JP, Li XX, Gao J, Liu CX. Determination and pharmacokinetics of danshensu in rat plasma after oral administration of Danshen extract using liquid chromatography/tandem mass spectrometry. Eur J Drug Metab Pharmacokinet 2008;33:9-16. (Pubitemid 351629148)
83. Liu Q, Chao RB. Determination of danshensu in urine and its pharmacokinetics in human. [in Chinese]. Yao Xue Xue Bao/Acta Pharma Sinica 2003;38:771-4.
84. Lu T, Yang J, Gao X, Chen P, Du F, Sun Y, et al. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine. Drug Metab Dispos 2008;36:1578-86.
85. Li X, Wang L, Li Y, Xu Y, Xue M. Simultaneous determination of danshensu, ferulic acid, cryptotanshinone and tanshinone IIA in rabbit plasma by HPLC and their pharmacokinetic application in danxiongfang. J Pharm Biomed Anal 2007;44:1106-12. (Pubitemid 47239299)
86. Zhao D, Han DE, Li N, Lu Y, Li TT, Yang SY, et al. Simultaneous determination of six phenolic constituents of Danshen injection in rat plasma by LC-ESI-MS and its application to a phar-macokinetic study. Eur J Mass Spectrom (Chichester, Eng) 2011;17:395-403.
87. Guo X, Chen X, Li L, Shen Z, Wang X, Zheng P, et al. LC-MS determination and pharmacokinetic study of six phenolic components in rat plasma after taking traditional Chinese medicinal-preparation: Guanxinning lyophilized powder for injection. J Chromatogr B Analyt Technol Biomed Life Sci 2008;873:51-8.
88. Hou YY, Peng JM, Chao RB. Pharmacokinetic study of salvi-anolic acid A in rat after intravenous administration of Danshen injection. Biomed Chromatogr 2007;21:598-601.
89. Han DE, Gao ZD, Zhao D, Wang L, Li N, Li TT, et al. Liquid chromatography mass spectrometry for the determination of salvianolic acid B, a natural compound from the herb Danshen in rat plasma and application to pharmacokinetic study. Biomed Chromatogr 2009;23:1073-8.
90. Du W, Wei YH, Zhao G, Qin HY, Wu XA. Determination of tanshinone I in rat plasma by high-performance liquid chro-matography and its application to pharmacokinetic studies. J Chromatogr Sci 2008;46:730-4.
91. Chang BB, Zhang L, Cao WW, Cao Y, Yang WL, Wang Y, et al. Pharmacokinetic interactions induced by content variation of major water-soluble components of Danshen preparation in rats. Acta Pharmacol Sin 2010;31:638-46.
92. Lai XJ, Zhang L, Li JS, Liu HQ, Liu XH, Di LQ, et al. Comparative pharmacokinetic and bioavailability studies of three salvianolic acids after the administration of Salviae miltiorrhizae alone or with synthetical borneol in rats. Fitoterapia 2011;82:883-8.
93. Hao H, Wang G, Li P, Li J, Ding Z. Simultaneous quantification of cryptotanshinone and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC-MS/MS). J Pharm Biomed Anal 2006;40:382-8. (Pubitemid 43143343)
94. Song M, Hang TJ, Zhang Zh X, Du R, Chen J. Determination of cryptotanshinone and its metabolite in rat plasma by liquid chromatography- tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2005;827:205-9. (Pubitemid 41570117)
95. Guo ZJ, Zhang Y, Tang X, Li H, Sun QS. Pharmacokinetic interaction between tanshinones and polyphenolic extracts of salvia miltinorrhiza BUNGE after intravenous administration in rats. Biol Pharm Bull 2008;31:1469-74.
96. Hao H, Wang G, Cui N, Li J, Xie L, Ding Z. Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion. Planta Med 2006;72:1311-7. (Pubitemid 44862033)
97. Gupta D, Jalali M, Wells A, Dasgupta A. Drug-herb interactions: unexpected suppression of free Danshen concentrations by salicylate. J Clin Lab Anal 2002;16:290-4. (Pubitemid 35397103)
98. Shen Y, Wang X, Xu L, Liu X, Chao R. Characterization of metabolites in rat plasma after intravenous administration of sal-vianolic acid A by liquid chromatography/time-of-flight mass spectrometry and liquid chromatography/ion trap mass spec-trometry. Rapid Commun Mass Spectrom 2009;23:1810-6.
99. Li X, Yu C, Lu Y, Gu Y, Lu J, Xu W, et al. Pharmacokinetics, tissue distribution, metabolism, and excretion of depside salts from Salvia miltiorrhiza in rats. Drug Metab Dispos 2007;35:234-9. (Pubitemid 46148735)
100. Wang L, Zhang Q, Li X, Lu Y, Xue Z, Xuan L, et al. Pharmacokinetics and metabolism of lithospermic acid by LC/MS/MS in rats. Int J Pharm 2008;350:240-6.
101. Xu M, Fu G, Qiao X, Wu WY, Guo H, Liu AH, et al. HPLC method for comparative study on tissue distribution in rat after oral administration of salvianolic acid B and phenolic acids from Salvia miltiorrhiza. Biomed Chromatogr 2007;21:1052-63. (Pubitemid 47490315)
102. Liu J, Wu J, Wang X, Cai Z. Study of the phase I and phase II metabolism of a mixture containing multiple tanshinones using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2007;21:2992-8. (Pubitemid 47401435)
103. Li P, Wang GJ, Li J, Hao HP, Zheng CN. Characterization of metabolites of tanshinone IIA in rats by liquid chromatography/tandem mass spectrometry. J Mass Spectrom 2006;41:670-84. (Pubitemid 44023122)
104. Li P, Wang GJ, Li J, Hao HP, Zheng CN. Identification of tanshinone IIA metabolites in rat liver microsomes by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2006;1104:366-9. (Pubitemid 43099910)
105. Sun J, Yang M, Han J, Wang B, Ma X, Xu M, et al. Profiling the metabolic difference of seven tanshinones using high-performance liquid chromatography/multi-stage mass spec-trometry with data-dependent acquisition. Rapid Commun Mass Spectrom 2007;21:2211-26. (Pubitemid 47121152)
106. Wang M, Dai H, Li X, Li Y, Wang L, Xue M. Structural elucidation of metabolites of tanshinone I and its analogue dihydrotan-shinone I in rats by HPLC-ESI-MSn. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:915-24.
107. Dai H, Wang M, Li X, Wang L, Li Y, Xue M. Structural elucidation of in vitro and in vivo metabolites of cryptotanshi-none by HPLC-DAD-ESI-MS(n). J Pharm Biomed Anal 2008;48:885-96.
108. Wang Q, Hao H, Zhu X, Yu G, Lai L, Liu Y, et al. Regioselective glucuronidation of tanshinone iia after quinone reduction: identification of human UDP-glucuronosyltransferases, species differences, and interaction potential. Drug Metab Dispos 2010;38:1132-40.
109. Hao H, Wang G, Cui N, Li J, Xie L, Ding Z. Identification of a novel intestinal first pass metabolic pathway: NQO1 mediated quinone reduction and subsequent glucuronidation. Curr Drug Metab 2007;8:137-49. (Pubitemid 46218680)
110. Bi HC, Law FC, Zhong GP, Xu CS, Pan Y, Ding L, et al. Study of tanshinone IIA tissue distribution in rat by liquid chromatog-raphy-tandem mass spectrometry method. Biomed Chromatogr 2007;21:473-9. (Pubitemid 46744732)
111. Bi HC, Zuo Z, Chen X, Xu CS, Wen YY, Sun HY, et al. Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases. Xenobiotica 2008;38:185-222.
112. Wang X, Yeung JH. Effects of Salvia miltiorrhiza extract on the liver CYP3A activity in humans and rats. Phytother Res 2011;25:1653-9.
113. Wang X, Yeung JH. Investigation of cytochrome P450 1A2 and 3A inhibitory properties of Danshen tincture. Phytomedicine 2012;19:348-54.
114. Wang X, Cheung CM, Lee WY, Or PM, Yeung JH. Major tan-shinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro. Phytomedicine 2010;17:868-75.
115. Qiu F, Zhang R, Sun J, Jiye A, Hao H, Peng Y, et al. Inhibitory effects of seven components of Danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes. Drug Metab Dispos 2008;36:1308-14. (Pubitemid 351929315)
116. Lee JH, Shin YJ, Kim HJ, Oh JH, Jang YP, Lee YJ. Danshen extract does not alter pharmacokinetics of docetaxel and clopi-dogrel, reflecting its negligible potential in P-glycoprotein-and cytochrome P4503A-mediated herb-drug interactions. Int J Pharm 2011;410:68-74.
117. He F, Bi HC, Xie ZY, Zuo Z, Li JK, Li X, et al. Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high-throughput inhibition screening of terpenoids. Rapid Commun Mass Spectrom 2007;21:635-43. (Pubitemid 46340306)
118. Wang X, Lee WY, Or PM, Yeung JH. Effects of major tanshino-nes isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substrates. Phytomedicine 2009;16:712-25.
119. Ueng YF, Kuo YH, Peng HC, Chen TL, Jan WC, Peter Guengerich F, et al. Diterpene quinone tanshinone IIA selectively inhibits mouse and human cytochrome p4501A2. Xenobiotica 2003;33:603-13.
120. Wang X, Yeung JH. Inhibitory effect of tanshinones on rat CYP3A2 and CYP2C11 activity and its structure-activity relationship. Fitoterapia 2011;82:539-45.
121. Wang X, Lee WY, Or PM, Yeung JH. Pharmacokinetic interaction studies of tanshinones with tolbutamide, a model CYP2C11 probe substrate, using liver microsomes, primary hepatocytes and in vivo in the rat. Phytomedicine 2010;17:203-11.
122. Liu HX, Hu Y, Liu Y, He YQ, Li W, Yang L. Hydroxylation of tanshinone IIa in human liver microsomes is specifically catalysed by cytochrome P4502A6. Xenobiotica 2009;39:382-90.
123. Wan RZ, Zhou MJ, Liu CX. The effects of salvianolic acid B from radix salvia miltiorrhizae on the oral pharmacokinet-ics of metoprolol and metoprolol acid in rats. Phytother Res 2010;24:846-51.
124. Ferguson SS, Chen Y, LeCluyse EL, Negishi M, Goldstein JA. Human CYP2C8 is transcriptionally regulated by the nuclear receptors constitutive androstane receptor, pregnane X receptor, glucocorticoid receptor, and hepatic nuclear factor 4alpha. Mol Pharmacol 2005;68:747-57. (Pubitemid 41206028)
125. Huang L, Bi HC, Liu YH, Wang YT, Xue XP, Huang M. CAR-mediated up-regulation of CYP3A4 expression in LS174T cells by Chinese herbal compounds. Drug Metab Pharmacokinet 2011;26:331-40.
126. Wang X, Lee WY, Zhou X, Or PM, Yeung JH. A pharmaco-dynamic- pharmacokinetic (PD-PK) study on the effects of Danshen (Salvia miltiorrhiza) on midazolam, a model CYP3A probe substrate, in the rat. Phytomedicine 2010;17:876-83.
127. Yang XF, Wang NP, Lu WH, Zeng FD. Effects of Ginkgo biloba extract and tanshinone on cytochrome P-450 isozymes and gluta-thione transferase in rats. Acta Pharmacol Sin 2003;24:1033-8.
128. Jinping Q, Peiling H, Yawei L, Abliz Z. Effects of the aqueous extract from Salvia miltiorrhiza Bge on the pharmacokinetics of diazepam and on liver microsomal cytochrome P450 enzyme activity in rats. J Pharm Pharmacol 2003;55:1163-7. (Pubitemid 36998659)
129. Yu C, Ye S, Sun H, Liu Y, Gao L, Shen C, et al. PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA. Chem Biol Interact 2009;177:58-64.
130. Liu YH, Mo SL, Bi HC, Hu BF, Li CG, Wang YT, et al. Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study. Xenobiotica 2011;41:259-80.
131. Qiu F, Wang G, Zhang R, Sun J, Jiang J, Ma Y. Effect of Danshen extract on the activity of CYP3A4 in healthy volunteers. Br J Clin Pharmacol 2010;69:656-62.
132. Kuo YH, Lin YL, Don MJ, Chen RM, Ueng YF. Induction of cytochrome P450-dependent monooxygenase by extracts of the medicinal herb Salvia miltiorrhiza. J Pharm Pharmacol 2006;58:521-7.
133. Lee WY, Zhou X, Or PM, Kwan YW, Yeung JH. Tanshinone I increases CYP1A2 protein expression and enzyme activity in primary rat hepatocytes. Phytomedicine 2012;19:169-76
134. Ueng YF, Kuo YH, Wang SY, Lin YL, Chen CF. Induction of CYP1A by a diterpene quinone tanshinone IIA isolated from a medicinal herb Salvia miltiorrhiza in C57BL/6J but not in DBA/2J mice. Life Sci 2004;74:885-96.
135. Zhang R, Sun J, Ma L, Wu X, Pan G, Hao H, et al. Induction of cytochromes P450 1A1 and 1A2 by tanshinones in human HepG2 hepatoma cell line. Toxicol Appl Pharmacol 2011;252:18-27.
136. Qiu F, Wang G, Zhao Y, Sun H, Mao G, Sun J. Effect of danshen extract on pharmacokinetics of theophylline in healthy volunteers. Br J Clin Pharmacol 2008;65:270-4. (Pubitemid 351192820)
137. Gao DY, Han LM, Zhang LH, Fang XL, Wang JX. Bioavailability of salvianolic acid B and effect on blood viscosities after oral administration of salvianolic acids in beagle dogs. Arch Pharm Res 2009;32:773-9.
138. Kim HH, Kim J, Ji HY, Kim YC, Sohn DH, Lee BM, et al. Pharmacokinetics of lithospermic acid B isolated from Salvia miltiorrhiza in rats. J Toxicol Environ Health A 2005;68:2239-47. (Pubitemid 41755680)
139. Zhang YJ, Wu L, Zhang QL, Li J, Yin FX, Yuan Y. Pharmacokinetics of phenolic compounds of Danshen extract in rat blood and brain by microdialysis sampling. J Ethnopharmacol 2011;136:129-36.
140. Ling W, Rui LC, Hua JX. In situ intestinal absorption behaviors of tanshinone IIA from its inclusion complex with hydroxypro-pyl-beta-cyclodextrin. Biol Pharm Bull 2007;30:1918-22. (Pubitemid 47607786)
141. Yu XY, Lin SG, Zhou ZW, Chen X, Liang J, Liu PQ, et al. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge. Curr Drug Metab 2007;8:325-40. (Pubitemid 46780062)
142. Chen X, Zhou ZW, Xue CC, Li XX, Zhou SF. Role of P-glycoprotein in
143. Yu XY, Zhou ZW, Lin SG, Chen X, Yu XQ, Liang J, et al. Role of ATP-binding cassette drug transporters in the intestinal absorption of tanshinone IIB, one of the major active diterpenoids from the root of Salvia miltiorrhiza. Xenobiotica 2007;37:375-415. (Pubitemid 46572883)
144. Zhou ZW, Chen X, Liang J, Yu XY, Wen JY, Zhou SF. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier. Drug Metab Lett 2007;1:205-17.
145. Zhang J, Huang M, Guan S, Bi HC, Pan Y, Duan W, et al. A mechanistic study of the intestinal absorption of cryptotan-shinone, the major active constituent of Salvia miltiorrhiza. J Pharmacol Exp Ther 2006;317:1285-94. (Pubitemid 43764135)
146. Yu XY, Lin SG, Chen X, Zhou ZW, Liang J, Duan W, et al. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier. Curr Drug Metab 2007;8:365-78.
147. Li XX, Zhou ZW, Zhou SF. Role of P-glycoprotein in the transport of tanshinone I, one active triterpenoid from Salvia miltior-rhiza. Drug Metab Lett 2008;2:223-30.
148. Yu PF, Wang WY, Eerdun G, Wang T, Zhang LM, Li C, et al. The role of p-glycoprotein in transport of danshensu across the blood-brain barrier. Evid Based Complement Alternat Med 2011;2011:713523.
149. Xiao YY, Chen ZP, Ping QN, Chen HX. The enhancing effect of borneol on the absorption of tetramethylpyrazine. [in Chinese]. Yao Xue Xue Bao/Acta Pharma Sinica 2009;44:915-21.